Morphine 30mg – 30 tablets

$500.00

Morphine is an opioid medication. An opioid is sometimes called a narcotic.
Morphine is used to treat moderate to severe pain. Short-acting formulations are taken as needed for pain.
The extended-release form of morphine is for around-the-clock treatment of pain. This form of morphine is not for use on an as-needed basis for pain.

Category:

Description

Generic Name: morphine (MOR feen) SULFATE Extended-release Tablets (MS Contin …
Brand Names: Arymo ER, Kadian, MorphaBond ER, MS Contin
What is morphine?
Morphine is an opioid medication. An opioid is sometimes called a narcotic.
is used to treat moderate to severe pain. Short-acting formulations are taken as needed for pain.
The extended-release form of morphine is for around-the-clock treatment of pain. This form of morphine is not for use on an as-needed basis for pain.
Important Information
You should not take morphine if you have severe asthma or breathing problems, a blockage in your stomach or intestines, or a bowel obstruction called paralytic ileus.
Morphine can slow or stop your breathing, and may be habit-forming MISUSE OF OPIOID MEDICINE CAN CAUSE ADDICTION, OVERDOSE, OR DEATH, , especially in a child or other person using the medicine without a prescription. Keep the medication in a place where others cannot get to it.MORPHINE SULFATE Extended-release Tablets (MS Contin …
Taking opioid medicine during pregnancy may cause life-threatening withdrawal symptoms in the newborn.
Fatal side effects can occur if you use opioid medicine with alcohol, or with other drugs that cause drowsiness or slow your breathing.
Brand-name drugs (the reference drug or first time the drug is approved by the Health Authority) are prescription pharmaceuticals that are protected by patents or other forms of exclusivity. These drugs, must first gain approval from a country’s regulatory authority. Applications for approval typically includes documentation that establishes a drug’s clinical safety and efficacy. Once the drug receives approval, the innovator company can then exclusively market and sell the “brand-name” product, for as long as they have patent protection or market exclusivity.

Developing new medicines can take years and significant investment. Only a few promising therapies ever enter clinical trials. Fewer still are approved for sale by health authorities, at which point marketing to healthcare providers and consumers begins.

Because patents and exclusivities can last many years, they serve as an incentive to developers. During the periods protected, developers generally recoup their investments and earn a profit.